Objective: Firstly, to investigate whether polycystic ovary syndrome (PCOS) shows a continuum of severity with increasing number of phenotypic features comprising the Rotterdam criteria for PCOS and secondly, to explore relationships of these phenotypes to the circadian biomarkers, cortisol and melatonin.
| INTRODUC TI ON
and neonatal complications. [8] [9] [10] Notably, little emphasis has been given to the distinction among women who manifest zero, one or two of the three phenotypic features comprising the Rotterdam criteria (PCOS features). In particular, it is unclear whether women with a single feature are more similar to those with none than to those with two features.
The aetiology of polycystic ovary syndrome (PCOS) has challenged reproductive scientists and clinicians since the syndrome was first described by Stein and Leventhal more than80 years ago.
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Cortisol and melatonin (N-acetyl-5-methoxytryptamine) are two well-recognized biomarkers of the circadian rhythm which are crucial for regulating sleep-wake cycles. In humans, these hormones are secreted in a distinct diurnal pattern where cortisol peaks in the early morning 12 and melatonin is highest in the early night. 13 Few studies have been carried out to explore the potential roles of melatonin and cortisol in the pathogenesis of PCOS, and results of those studies have been inconsistent, with some reports of increased night-time melatonin levels, 14, 15 one study reporting higher mean values over 24 hours 16 and another which reported higher morning but not night melatonin levels. One study found increased morning and night cortisol secretion in women with PCOS, 17 yet another study reported no significant differences. 18 We hypothesized that PCOS would show a continuum of severity according to the number of phenotypic features. Therefore, our primary aim was to evaluate the relationship between the androgenic, ovarian, pituitary and metabolic characteristics typically associated with PCOS with increasing number of PCOS features. Additionally, we were also interested in exploring the associations between circadian biomarkers and the phenotypic spectrum of PCOS.
| ME THODS

| Study design, setting and population
This is a cross-sectional study carried out at the National University Participants were classified as having either zero, one, two or all three of the following phenotypic features of PCOS: hyperandrogenism, oligo/amenorrhoea or polycystic ovarian morphology.
Hyperandrogenism was defined as having either one of the fol- for PCOS were obtained using sensitivity/specificity analyses and receiver operating characteristic curves that best predicted oligomenorrhoea/anovulation in a healthy non-PCOS population.
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ADT and DHEAS were NUH laboratory thresholds for women.
| Menstrual cycle length
Menstrual cycle length was classified into three categories for analysis: <25 days (short), 25-34 days (normal) or ≥35 days (long). 
| Hyperandrogenism
Assessment of hirsutism by modified Ferriman-Gallwey (mFG) scoring and measurement of circulating testosterone, DHEAS, ADT and sex hormone-binding globulin (SHBG) were performed as previously described.
21,22
| Ovarian morphology
Morphometric analysis of the ovaries was performed by transvaginal ultrasonography as described previously. 21 Women with at least one ovarian cyst or follicle exceeding a diameter of 10 mm, even after repeated evaluation in their following cycle, were excluded to eliminate the possibility of a spuriously large ovarian volume and endocrine effects from a developing dominant follicle. Derivation of antral follicle counts and ovarian volume were as described previously.
| Anthropometric and metabolic variables
Physical measurements included height, weight, waist circumference and blood pressure. Glucose, insulin and lipids (cholesterol, triglycerides, high-density lipoprotein [HDL] and low-density F I G U R E 1 Flow chart of exclusion criteria, derivation of the final study population and classification by number of PCOS criteria lipoprotein [LDL]) were measured as described previously. 21, 22 Body mass index (BMI), waist to hip ratio (WHR), the homoeostasis model assessment-estimated insulin resistance (HOMA-IR) and presence of metabolic syndrome were determined from those measurements as described previously. 22 
| Other biochemical analysis
Prolactin, oestradiol, AMH, LH and FSH were measured using immunoassays, as described previously. 21, 22 In addition, we investigated whether the number of PCOS phenotypic features was associated with serum cortisol and melatonin, two well-recognized biomarkers of the circadian rhythm crucial for regulating sleep-wake cycles. Serum melatonin and cortisol were measured by ELISA (IBL, Germany), according to the manufacturer's instructions.
Apart from AMH which was assayed weekly, and melatonin and cortisol which were batch-analysed at the end of the study, all other biochemical analyses were performed within the same day of blood sampling. Biochemical analyses and assay performance characteristics are summarized in Table S1 .
| Health and lifestyle questionnaire
Study women were required to report on lifestyle factors that potentially influence circadian rhythms and reproductive health.
Details of the questionnaire were as described previously. 22 Briefly, lifestyle factors were dichotomized for shift work (yes/no), sleep length (<6 hours/≥6 hours), smoking (yes/no), exercise (regularly vs not), alcohol consumption (never or occasionally/once a week or more) and coffee consumption (<1 cup per day/≥1 cup per day).
Stress was recorded on a scale of increasing magnitude ranging from 1 to 10. Additionally, participants were asked to state any previous medical history of depression, anxiety, stress or sleep disorders. 
| Statistical analysis
| RE SULTS
As shown in Figure 1 We observed a highly significant positive linear trend in both melatonin (P < 0.001) and cortisol levels (P = 0.003) with an increasing number of PCOS features. Similar results were obtained when we restricted the analysis to women from the health screen and university community (ie, excluding those recruited from the gynaecology clinics), although the differences did not achieve statistical significance, likely owing to the reduced sample size Table 3 .
No significant associations between other cardiometabolic outcomes (blood pressure, serum lipid levels or frequency of metabolic syndrome) and the number of PCOS features were observed. (8) 9 (7) 8 (9) 6 (9) 3 (7) (Continues)
TA B L E 1 Basic characteristics of the study population by number of phenotypic features comprising the Rotterdam criteria for PCOS
| D ISCUSS I ON
We observed a highly significant linear trend between the number The phenotypic severity of PCOS remains a subject of much debate. PCOS is a reproductive disorder associated with increased metabolic risk, and infertility is therefore a logical candidate for assessing severity. Studies on fertility outcomes across the PCOS phenotypic spectrum are scarce, although a handful of studies have reported on pregnancy and neonatal complications across the four Rotterdam phenotypes. [8] [9] [10] Current classification of PCOS severity is more often based on long-term metabolic risks. 25 The strong association we observed between the number of PCOS features and severity of PCOS (as measured by androgenic, ovarian and menstrual characteristics, as well as BMI, insulin and HOMA-IR) suggests that this continuous measure may better represent the phenotypic spectrum of PCOS than the traditional dichotomous classification.
Additionally, our study is the first to show a strong positive relationship between number of PCOS features and two biomarkers of circadian rhythm, melatonin and cortisol. In particular, the most severe group (manifesting all three PCOS features) had significantly higher mean melatonin and cortisol levels compared with women with none of the features, even after adjustment for potential confounders. In humans, these hormones are secreted in a distinct diurnal pattern: cortisol peaks in the early morning 12 and melatonin peaks in the early night. 13 Few studies have been carried out to explore the potential roles of melatonin and cortisol in the pathogenesis of PCOS, and results of those studies have been inconsistent. [14] [15] [16] [17] [18] Since morning melatonin levels are expected to be low at daylight, our finding of high melatonin levels in the morning suggests a smaller night-day difference, possibly due to perturbed circadian rhythms in women with PCOS. Unlike melatonin, which is principally regulated by photic stimuli and light-dark cycles, glucocorticoid secretion is low in the late afternoon and evening but rises markedly when the subject awakens and becomes active. Cortisol secretion rises steadily through the second half of the night, but exhibits a further marked increase during the first hour after waking from sleep. 26, 27 This response can be heightened among individuals experiencing job stress, overload, and low self-esteem. 28 In this respect, elevated cortisol in our PCOS subjects may be a sign of stress-induced hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, which may accentuate adrenal androgen excess and thereby lead to the more severe PCOS phenotypes we observed with higher cortisol levels. Taken together, the high morning melatonin and cortisol levels we observed in PCOS may be a sign of disrupted circadian rhythms and stress.
Further studies involving multiple daily blood sampling would help to confirm the possible circadian rhythm disruption in PCOS women.
An important strength of our study is that all participants underwent standardized tests and were properly assessed for the widely accepted Rotterdam criteria. One limitation of our study, however, was an insufficient sample size to identify which of the PCOS features-HA, OA or PCOM-made a larger contribution to the reproductive features and metabolic outcomes we studied.
Larger studies across different societies and cultures, and studies on the extent to which fertility outcomes are associated with the number of PCOS features would shed additional light on the PCOS spectrum.
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